DelveInsight launched a new report on Candidemia Epidemiology Forecast, 2030.
Candidemia is the most common fungal bloodstream infection and possibly the fourth most common all-type bloodstream infection seen in the intensive care unit setting. The incidence of Candida bloodstream infection is bimodal, with the elderly and very young having the highest risk of any population suffering from this disease.
DelveInsight’s ‘Candidemia Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Candidemia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the key highlights from the Candidemia Epidemiology Report:
Among the EU5 countries, the UK had the lowest incident population with 2,332 cases in 2017.
The incident population of candidemia in Japan was 916 cases in 2017.
In 2017, incident cases of candidemia in the US varied according to gender; 10,237 females and 12,563 males. These cases are expected to increase by 2030.
Visit for more @ Candidemia Epidemiology Insights
Scope of the Candidemia Epidemiology report:
The Candidemia report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
The Candidemia Epidemiology Report and Model provide an overview of the risk factors and global trends of Candidemia in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
The report provides insight into the historical and forecasted patient pool of Candidemia in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
The report helps to recognize the growth opportunities in the 7MM concerning the patient population
The report assesses the disease risk and burden and highlights the unmet needs of Candidemia
The report provides the segmentation of the Candidemia epidemiology
Table of Contents:
1. Key Insights
2. Executive Summary of Candidemia
3. Candidemia Epidemiology Overview at a Glance
4. Candidemia: Disease Background and Overview
5. Epidemiology and Patient Population
6. Case Reports
7. Country Wise-Epidemiology of Candidemia
9. DelveInsight Capabilities
11. About DelveInsight
DelveInsight’s ‘Candidemia-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
“Candidemia Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Candidemia market. A detailed picture of the Candidemia pipeline landscape is provided, which includes the disease overview and Candidemia treatment guidelines.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States